Search Results for 'hcv weeks'

hcv weeks published presentations and documents on DocSlides.

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Access to antiviral drugs for treating HCV for HIV-positive
Access to antiviral drugs for treating HCV for HIV-positive
by yoshiko-marsland
AIDS 2016 | 18-22 July 2016 | Durban, South A...
INTEGRATING HIV AND HCV TESTING
INTEGRATING HIV AND HCV TESTING
by cheryl-pisano
30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 2...
HCV 2016  Alex Rodgers Hepatologist
HCV 2016 Alex Rodgers Hepatologist
by radions
. FMC. Disclosures. nil. Learning objectives/. t. ...
The goal of hepatitis C virus (HCV) treatment is a cure (when there is
The goal of hepatitis C virus (HCV) treatment is a cure (when there is
by amey
Genotype 1, never treated for HCV, no cirrhosis12 ...
EASL 2019 HCV Conference Update
EASL 2019 HCV Conference Update
by sophia
April 10. –14. , 2019. Vienna, Austria. Disclaim...
Prevention strategies for HIV/HCV co infection
Prevention strategies for HIV/HCV co infection
by giovanna-bartolotta
Isabelle Andrieux-Meyer, MD. Médecins Sans Front...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
Hepatitis C: A New Era In Treatment And Cure
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
www.hcvadvocate.org BLOG:  hcvadvocate.blogspot.com
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
by luanne-stotts
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
Telaprevir in Treatment
Telaprevir in Treatment
by liane-varnes
NaĂŻve GT-1. ILLUMINATE (Study 111). Phase . 3. T...
Making the Impossible Possible
Making the Impossible Possible
by phoebe-click
Eradicate Hepatitis C Virus . A pilot of treatmen...
MEDICAL CENTER “MRCHEVELI”
MEDICAL CENTER “MRCHEVELI”
by elina
MEDICAL CENTER “MRCHEVELI”. Case Presentation:...
GP Study Afternoon: Viral Hepatitis
GP Study Afternoon: Viral Hepatitis
by madison
Cockburn Lecture Theatre, St Marys Hospital. Wedne...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by webraph
Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
The Hepatitis Viruses Jayesh
The Hepatitis Viruses Jayesh
by conchita-marotz
A. Patel, MD, DTM&H. Learning Your “A B C ...
2014: HIV, HCV, and  HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
by min-jolicoeur
Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...
Ledipasvir-Sofosbuvir   RBV in HCV GT 1,4 and Advanced Liver Disease
Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease
by alida-meadow
SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...
Advances in the Treatment of
Advances in the Treatment of
by danika-pritchard
HCV Genotype 3 and HIV/HCV Coinfection . What's S...
Ledipasvir-Sofosbuvir (
Ledipasvir-Sofosbuvir (
by lindy-dunigan
Harvoni. ). Prepared by: . David H. Spach, MD and...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
TURQUOISE-II
TURQUOISE-II
by pasty-toler
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
Hepatitis C Drug 		 	   Pipeline
Hepatitis C Drug Pipeline
by cheryl-pisano
HCV WORLD CAB .  FEBRUARY 2014. BANGKOK, THAI...
Trent W Nichols
Trent W Nichols
by cheryl-pisano
Hepatitis-2015. Orlando. , USA. July 20 - 22 20...
TURQUOISE-II
TURQUOISE-II
by giovanna-bartolotta
OBV/PTV/r . + . DSV . + RBV. OBV/PTV/r + . DSV . ...
New IDSA/AASLD Guidelines for Hepatitis C
New IDSA/AASLD Guidelines for Hepatitis C
by debby-jeon
John Scott, MD, MSc. Associate Professor, UW . So...
HIV and HCV Update for the Pharmacist – June 2014
HIV and HCV Update for the Pharmacist – June 2014
by marina-yarberry
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...
Out With the Old and In With the New, Again?
Out With the Old and In With the New, Again?
by test
Out With the Old, In With the New. Current Standa...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
SMV 150 mg QD   SOF 400 mg QD
SMV 150 mg QD SOF 400 mg QD
by alida-meadow
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
M.W. Fried , 1  M. Buti,
M.W. Fried , 1 M. Buti,
by iamamercy
2. G.J. Dore,. 3. P. Ferenci,. 4. . I. Jacobson...
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
C-WORTHY/B
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
Ombitasvir-
Ombitasvir-
by min-jolicoeur
Paritaprevir. -. Ritonavir (. Technivie. ). Prepa...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...
Treatment for 12 or 24 weeks with BI201335 combined with pe
Treatment for 12 or 24 weeks with BI201335 combined with pe
by lindy-dunigan
Results of the SILEN-C3 trial. SILEN-C3 trial . M...
Peginterferon alfa-2a (
Peginterferon alfa-2a (
by tatyana-admore
Pegasys. ). Prepared by: David Spach, MD & H....
Updated Guidelines for Managing HIV/HCV Co-Infection
Updated Guidelines for Managing HIV/HCV Co-Infection
by karlyn-bohler
John J . Faragon. , . PharmD. , BCPS, AAHIV-P. Re...